Stocks
AbbVie Inc.ABBV
NYSEHealthcarePharmaceuticals$219.68-2.52%
A large U.S. biopharmaceutical company focused on immunology, oncology, neuroscience, and aesthetics medicines. Its portfolio includes blockbuster drugs such as Skyrizi and Rinvoq, as well as Botox and other aesthetics products acquired through the Allergan deal. Investors closely watch the company ...
Market Cap: $388.4B52W Range: $164.39 – $244.81
This page tracks all publicly disclosed congressional trades in AbbVie Inc. (ABBV), a company in the Healthcare sector. 11 members of Congress have disclosed trades in this stock, including 26 purchases and 22 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
50
Unique Politicians
11
Buys
26
Sells
22
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-02-05 | Rohit Khanna | buy | $1K – $15K |
| 2026-01-29 | Rohit Khanna | sell | $15K – $50K |